Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Apyx Medical (APYX) Receivables - Net (2016 - 2025)

Apyx Medical's Receivables - Net history spans 16 years, with the latest figure at $16.8 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 8.37% year-over-year to $16.8 million; the TTM value through Dec 2025 reached $16.8 million, up 8.37%, while the annual FY2025 figure was $16.8 million, 8.37% up from the prior year.
  • Receivables - Net reached $16.8 million in Q4 2025 per APYX's latest filing, up from $13.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $16.8 million in Q4 2025 to a low of $7.7 million in Q1 2021.
  • Average Receivables - Net over 5 years is $11.9 million, with a median of $12.2 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: soared 85.96% in 2021, then decreased 20.53% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $13.0 million in 2021, then dropped by 18.68% to $10.6 million in 2022, then surged by 32.27% to $14.0 million in 2023, then rose by 10.39% to $15.5 million in 2024, then increased by 8.37% to $16.8 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Receivables - Net are $16.8 million (Q4 2025), $13.0 million (Q3 2025), and $11.2 million (Q2 2025).